查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2132589

門診輸液中心市場規模、佔有率和趨勢分析報告：按治療領域、所有權類型、年齡層、地區和細分市場分類的預測（2026-2033 年）

Ambulatory Infusion Centers Market Size, Share & Trends Analysis Report By Therapy Area (Oncology), By Ownership Model (Independent Centers), By Age Group, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 181 Pages | 商品交期: 2-10個工作天內

價格

門診靜脈輸液治療中心市場概述

全球門診靜脈輸液治療中心市場預計在 2025 年達到 409 億美元，預計從 2026 年的 437 億美元成長到 2033 年的 762 億美元，2026 年至 2033 年的複合年成長率為 8.3%。

北美是市場的主要驅動力，預計到2025年將佔據36.8%的最大市場佔有率。這一成長歸因於慢性病患病率的上升、專業靜脈輸液療法的日益普及以及人們轉向更經濟實惠的門診治療。此外，有利的報銷政策、對獨立靜脈輸液中心的投資增加以及患者對便捷、易得且個性化的靜脈輸液服務的需求日益成長，都進一步推動了市場擴張。

以下章節概述了門診靜脈輸液治療市場的主要促進因素，重點介紹了需要長期靜脈輸液治療的慢性疾病患病率不斷上升，以及從以醫院為中心的治療模式向更具成本效益的門診治療模式的轉變。我們也探討了以下幾個面向：生物製藥和注射療法的日益普及、有利的保險報銷政策、對獨立靜脈輸液治療檢驗的投資增加，以及患者對便捷、可及和個性化靜脈輸液治療服務的日益成長的需求。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：門診輸液中心市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 門診靜脈輸液中心市場分析工具

第4章：門診靜脈輸液治療中心市場：依治療領域分類的估算與趨勢分析

  • 按治療區域分類的市場佔有率，2025 年和 2033 年
  • 全球門診輸液中心市場：依治療領域分類，展望
    • 腫瘤學
    • 自體免疫/發炎性疾病
    • 神經病學
    • 感染疾病
    • 血液學
    • 免疫力缺乏
    • 內分泌/代謝疾病
    • 罕見疾病
    • 其他

第5章：門診靜脈輸液治療中心市場：按所有權模式分類的估算與趨勢分析

  • 按自有車型分類的市場佔有率，2025 年和 2033 年
  • 全球門診輸液中心市場：以所有權模式分類，展望
    • 獨立中心
    • 醫院管理中心
    • 醫生所有的中心
    • 由專業藥房營運的中心

第6章：門診靜脈輸液治療中心市場：按年齡層別分類的估算與趨勢分析

  • 按年齡層別分類的市場佔有率，2025 年和 2033 年
  • 全球門診輸液中心市場：依年齡層別分類，展望
    • 兒童
    • 成人
    • 老年人

第7章 門診靜脈輸液治療中心市場：按治療領域、所有權類型和年齡層分類的區域估計和趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 紐西蘭
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司和競爭對手的分類
  • 主要公司市場分析（2025 年）
    • Option Care Health, Inc.
    • Coram CVS Specialty Infusion Services
    • Amerita, Inc.
    • KabaFusion
    • Biomatrix 特藥藥房
    • Paragon Healthcare, Inc.
    • Healix, Inc.
    • Vivo Infusion
    • Pure Infusion
    • AIS Healthcare
Product Code: GVR-4-68041-016-0

Ambulatory Infusion Centers Market Summary

The global ambulatory infusion centers market size was estimated at USD 40.9 billion in 2025 and is projected to grow from USD 43.7 billion in 2026 to USD 76.2 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 36.8% in 2025. This growth is attributed to the increasing prevalence of chronic diseases, expanding use of specialty infusion therapies, and the shift toward cost-effective outpatient care. Moreover, favorable reimbursement policies, increasing investments in independent infusion centers, and growing patient preference for convenient, accessible, and personalized infusion services are further supporting market expansion.

The section below outlines the key factors driving the growth of the ambulatory infusion centers market, highlighting the rising prevalence of chronic diseases requiring long-term infusion therapies and the growing shift from hospital-based care to cost-effective outpatient settings. It also examines the increasing adoption of specialty biologics and injectable therapies, favorable reimbursement policies, expanding investments in independent infusion centers, and rising patient preference for convenient, accessible, and personalized infusion services.

Global Ambulatory Infusion Centers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on industry trends in each of the segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the ambulatory infusion centers market report on the basis of therapy area, ownership model, age group and region:

  • Therapy Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Autoimmune & Inflammatory Disorders
  • Neurology
  • Infectious Diseases
  • Hematology
  • Immunodeficiency Disorders
  • Endocrine & Metabolic Disorders
  • Rare Diseases
  • Others
  • Ownership Model Outlook (Revenue, USD Million, 2021 - 2033)
  • Independent Centers
  • Hospital-Owned Centers
  • Physician-Owned Centers
  • Specialty Pharmacy-Owned Centers
  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)
  • Pediatric
  • Adult
  • Geriatric
  • Regional Outlook (Revenue in USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • New Zealand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Therapy Area
    • 1.1.2. Ownership Model
    • 1.1.3. Age Group
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Therapy area outlook
    • 2.2.2. Ownership model outlook
    • 2.2.3. Age group outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ambulatory Infusion Centers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising adoption of biologic and specialty drugs
      • 3.2.1.2. Growing shift from hospital-based infusion to cost-effective ambulatory care
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Shortage of skilled infusion nurses and healthcare professionals
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. Ambulatory Infusion Centers Market Analysis Tools
    • 3.3.1. Porter's five forces analysis
    • 3.3.2. PESTLE analysis

Chapter 4. Ambulatory Infusion Centers Market: Therapy Area Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Therapy Area Market Share, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Ambulatory Infusion Centers Market by Therapy Area Outlook
    • 4.4.1. Oncology
      • 4.4.1.1. Oncology Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.2. Autoimmune & Inflammatory Disorders
      • 4.4.2.1. Autoimmune & Inflammatory Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.3. Neurology
      • 4.4.3.1. Neurology Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.4. Infectious Diseases
      • 4.4.4.1. Infectious Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.5. Hematology
      • 4.4.5.1. Hematology Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.6. Immunodeficiency Disorders
      • 4.4.6.1. Immunodeficiency Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.7. Endocrine & Metabolic Disorders
      • 4.4.7.1. Endocrine & Metabolic Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.8. Rare Diseases
      • 4.4.8.1. Rare Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.9. Others
      • 4.4.9.1. Others Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Ambulatory Infusion Centers Market: Ownership Model Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Ownership Model Market Share, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Ambulatory Infusion Centers Market by Ownership Model Outlook
    • 5.4.1. Independent Centers
      • 5.4.1.1. Independent Centers Market estimates and forecast, 2021 to 2033 (USD Million)
    • 5.4.2. Hospital-Owned Centers
      • 5.4.2.1. Hospital-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
    • 5.4.3. Physician-Owned Centers
      • 5.4.3.1. Physician-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
    • 5.4.4. Specialty Pharmacy-Owned Centers
      • 5.4.4.1. Specialty Pharmacy-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Ambulatory Infusion Centers Market: Age Group Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Age Group Market Share, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Ambulatory Infusion Centers Market by Age Group Outlook
    • 6.4.1. Pediatric
      • 6.4.1.1. Pediatric Market estimates and forecast, 2021 to 2033 (USD Million)
    • 6.4.2. Adult
      • 6.4.2.1. Adult Market estimates and forecast, 2021 to 2033 (USD Million)
    • 6.4.3. Geriatric
      • 6.4.3.1. Geriatric Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 7. Ambulatory Infusion Centers Market: Regional Estimates & Trend Analysis, By Therapy Area, By Ownership Model, By Age Group

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. New Zealand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market position analysis, 2025
    • 8.3.1. Option Care Health, Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Coram CVS Specialty Infusion Services
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Amerita, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. KabaFusion
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. BioMatrix Specialty Pharmacy
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Paragon Healthcare, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Healix, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Vivo Infusion
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Pure Infusion
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. AIS Healthcare
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 4 North America ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 5 North America ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 6 U.S. ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 7 U.S. ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 8 Canada ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 9 Canada ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 10 Canada ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 11 Mexico ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 12 Mexico ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 13 Mexico ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 14 Europe ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 15 Europe ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 16 Europe ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 17 UK ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 18 UK ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 19 UK ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 20 Germany ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 21 Germany ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 22 Germany ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 23 France ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 24 France ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 25 France ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 26 Italy ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 27 Italy ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 28 Italy ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 29 Spain ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 30 Spain ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 31 Spain ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 32 Sweden ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 33 Sweden ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 34 Sweden ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 35 Denmark ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 36 Denmark ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 37 Denmark ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 38 Norway ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 39 Norway ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 40 Norway ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 42 Asia Pacific ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 44 Japan ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 45 Japan ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 46 Japan ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 47 China ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 48 China ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 49 China ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 50 India ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 51 India ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 52 India ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 53 Australia ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 54 Australia ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 55 Australia ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 56 South Korea ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 57 South Korea ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 58 South Korea ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 59 Thailand ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 60 Thailand ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 61 Thailand ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 62 Latin America ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 63 Latin America ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 64 Latin America ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 65 Brazil ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 66 Brazil ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 67 Brazil ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 68 Argentina ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 69 Argentina ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 70 Argentina ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 71 MEA ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 72 MEA ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 73 MEA ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 74 South Africa ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 75 South Africa ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 76 South Africa ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 77 Saudi Arabia ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 78 Saudi Arabia ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 79 Saudi Arabia ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 80 UAE ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 81 UAE ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 82 UAE ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 83 Kuwait ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 84 Kuwait ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 85 Kuwait ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Ambulatory infusion centers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Supply-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Market segmentation
  • Fig. 10 Market segmentation
  • Fig. 11 Competitive landscape
  • Fig. 12 Parent market outlook
  • Fig. 13 Ambulatory infusion centers market dynamics
  • Fig. 14 Ambulatory infusion centers market: Porter's five forces analysis
  • Fig. 15 Ambulatory infusion centers market: PESTLE analysis
  • Fig. 16 Ambulatory infusion centers market: Therapy area segment dashboard
  • Fig. 17 Ambulatory infusion centers market: Therapy area market share analysis, 2025 & 2033
  • Fig. 18 Oncology ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 19 Autoimmune & inflammatory disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 20 Neurology ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 21 Infectious diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 22 Hematology ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 23 Immunodeficiency disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 24 Endocrine & metabolic disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 25 Rare diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 26 Others ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 27 Ambulatory infusion centers market: Ownership model segment dashboard
  • Fig. 28 Ambulatory infusion centers market: Ownership model market share analysis, 2025 & 2033
  • Fig. 29 Independent centers, market, 2021 - 2033 (USD Million)
  • Fig. 30 Hospital-owned centers, market, 2021 - 2033 (USD Million)
  • Fig. 31 Physician-owned centers, market, 2021 - 2033 (USD Million)
  • Fig. 32 Specialty pharmacy-owned centers, market, 2021 - 2033 (USD Million)
  • Fig. 33 Ambulatory infusion centers market: Age group segment dashboard
  • Fig. 34 Ambulatory infusion centers market: Age group market share analysis, 2025 & 2033
  • Fig. 35 Pediatric market, 2021 - 2033 (USD Million)
  • Fig. 36 Adults market, 2021 - 2033 (USD Million)
  • Fig. 37 Geriatric market, 2021 - 2033 (USD Million)
  • Fig. 38 Ambulatory infusion centers market revenue, by region, 2025 & 2033, (USD Million)
  • Fig. 39 Regional marketplace key takeaways
  • Fig. 40 Regional marketplace key takeaways
  • Fig. 41 North America ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 U.S. ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Canada ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Mexico ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 48 Europe ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Sweden ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Norway ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Denmark ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 China ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Australia ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Korea ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 New Zealand ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 78 Latin America ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Brazil ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Argentina ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 83 Middle East & Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 South Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Saudi Arabia ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 UAE ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Kuwait ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 92 Company/competition categorization
  • Fig. 93 Company market position analysis, 2025
  • Fig. 94 Strategy mapping